Summit Therapeutics Inc. (SMMT)
Healthcare · Pharmaceutical Preparations
Summit Therapeutics Inc. (SMMT) stock research on InvestAtlant: institutional ownership from 13F filings, insider Form 4 activity, and SEC context.
Top institutional holders (2026-Q2)
| Institution | Shares | Value | % Outstanding |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | 32,786,348 | $477.70M | 4.13% |
| FMR LLC | 10,043,947 | 46.34M | 1.27% |
| State Street Corp | 9,536,796 | 38.95M | 1.20% |
| BlackRock, Inc. | 9,529,041 | 38.84M | 1.20% |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,734,484 | $83.55M | 0.72% |
| UBS Group AG | 5,233,798 | $76.26M | 0.66% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5,042,190 | $73.46M | 0.64% |
| Goldman Sachs Group Inc | 4,513,399 | $65.76M | 0.57% |
Recent insider transactions
| Date | Insider | Title | Type | Value |
|---|---|---|---|---|
| 2026-06-12 | Zanganeh Mahkam | Co-Chief Executive Officer, Director, 10% Owner | Purchase | $49.99M |
| 2026-06-12 | DUGGAN ROBERT W | Co-Chief Executive Officer, Director, 10% Owner | Purchase | $49.99M |
| 2026-06-04 | DUGGAN ROBERT W | Co-Chief Executive Officer, Director, 10% Owner | Purchase | .46M |
| 2026-06-04 | Zanganeh Mahkam | Co-Chief Executive Officer, Director, 10% Owner | Purchase | .46M |
| 2026-06-04 | Soni Manmeet Singh | COO and CFO, Director | Purchase | $361.5K |
| 2026-06-04 | Soni Manmeet Singh | COO and CFO, Director | Purchase | $360.8K |
| 2025-10-21 | Xia Yu | Director | Purchase | 0.00M |
| 2025-10-21 | DUGGAN ROBERT W | Co-Chief Executive Officer, Director, 10% Owner | Purchase | $500.0K |